LifeLines
Interviews, insights, and innovation leading the way for life science.
Interviews
May 27, 2026
Member Spotlight: GATC Health
Your Story is Our Story
When it comes to CRISPR-based gene therapies, size isn’t just a detail—it’s a game-changer. Traditional gene editing relies on the Cas9 enzyme, a powerful tool but one with delivery and targeting challenges. Mammoth Biosciences is rewriting the rules with ultracompact Cas enzymes, enabling more precise in-vivo delivery, even in hard-to-reach tissues. Co-founded by CRISPR pioneer and Nobel laureate Jennifer Doudna, Ph.D., the company is moving beyond traditional gene splicing to develop more precise, controlled, and potentially safer therapies.
Join us for our video series, Your Story is Our Story, featuring groundbreaking achievements and exclusive behind-the-scenes looks at pioneering companies shaping the future of life science in California.
#interviews
Interviews
Member Spotlight
March 26, 2026
Member Spotlight: BrainChild Bio
Member Spotlight
January 29, 2026
Member Spotlight: Rosebud Biosciences
Member Spotlight
August 28, 2025
Member Spotlight: Acurion
Member Spotlight
April 30, 2025
Member Spotlight: Pivot Bio
Insights
Innovations
Catalyst Awards
October 27, 2025
Meet Our 2025 Catalyst Awards Winners
Catalyst Awards